Entries tagged "Bayer"
Bayer AG's CEO Arthur Higgins told The Wall Street Journal the healthcare company may swallow up some smaller healthcare businesses in the next six to 24 months. No surprise given its acquisition pace so far this year, but Higgins told the Journal that the company is interested in acquiring businesses that make over-the-counter drugs, medications for animals and medical devices, which would be a divergence from its recent deals. ...
Indiplon. Exubera. Dalbavancin. Torcetrapib. Chantix. Quick quiz: What do these names have in common? No, they're not rap stars or distant planets. They're all high-profile drugs from New York's Pfizer Inc. that have tanked or run into big problems the past couple years. The antibiotic dalbavancin, aimed at nasty super-resistant bugs like MRSA, was in line for regulatory approval when Pfizer said Tuesday it would have to put it through more testing.Pfizer's poor track record of late was the backdrop to unfounded rumors Tuesday morning that it was mulling a takeover bid of Germany's Bayer AG. Investors reacted by driving...
Takeover rumors of Bayer AG by New York-based Pfizer Inc. boosted shares of the German drugs and chemicals group Tuesday morning. ...
